These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 21880046

  • 1. Cost-effectiveness of additional blood screening tests in the Netherlands.
    Borkent-Raven BA, Janssen MP, van der Poel CL, Bonsel GJ, van Hout BA.
    Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
    [Abstract] [Full Text] [Related]

  • 2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 3. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
    van Hulst M, Hubben GA, Sagoe KW, Promwong C, Permpikul P, Fongsatitkul L, Glynn DM, Sibinga CT, Postma MJ.
    Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands.
    Borkent-Raven BA, Janssen MP, van der Poel CL, de Wit GA, Bonsel GJ, van Hout BA.
    Transfusion; 2009 Feb; 49(2):311-9. PubMed ID: 19389213
    [Abstract] [Full Text] [Related]

  • 5. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [Abstract] [Full Text] [Related]

  • 6. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 7. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP.
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [Abstract] [Full Text] [Related]

  • 8. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L, AbdulRahman M, John TJ, AlHashimi A.
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [Abstract] [Full Text] [Related]

  • 9. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010.
    Dorsey KA, Moritz ED, Steele WR, Eder AF, Stramer SL.
    Transfusion; 2013 Jun; 53(6):1250-6. PubMed ID: 23003320
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A.
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [Abstract] [Full Text] [Related]

  • 11. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
    Jarvis LM, Dow BC, Cleland A, Davidson F, Lycett C, Morris K, Webb B, Jordan A, Petrik J.
    Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
    [Abstract] [Full Text] [Related]

  • 12. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S, Dodd RY, Stramer SL, Strong DM, Tissue Safety Study Group.
    N Engl J Med; 2004 Aug 19; 351(8):751-9. PubMed ID: 15317888
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M, Sagoe KW, Vermande JE, van der Schaaf IP, van der Tuuk Adriani WP, Torpey K, Ansah J, Mingle JA, Smit Sibinga CT, Postma MJ.
    Value Health; 2008 Aug 19; 11(5):809-19. PubMed ID: 18489518
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.
    Transfusion; 2007 Oct 19; 47(10):1803-8. PubMed ID: 17880604
    [Abstract] [Full Text] [Related]

  • 15. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S, Notari EP, Fang CT, Stramer SL, Dodd RY.
    Transfusion; 2009 Apr 19; 49(4):655-61. PubMed ID: 19170999
    [Abstract] [Full Text] [Related]

  • 16. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb 19; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 17. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb 19; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 18. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun 19; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Mafirakureva N, Mapako T, Khoza S, Emmanuel JC, Marowa L, Mvere D, Postma MJ, van Hulst M.
    Transfusion; 2016 Dec 19; 56(12):3101-3111. PubMed ID: 27696441
    [Abstract] [Full Text] [Related]

  • 20. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.
    CMAJ; 2003 Oct 14; 169(8):767-73. PubMed ID: 14557314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.